Defining a new era of oligonucleotides

Defining a new era of oligonucleotides

424B5

SEC Filing Details

Document Details

Form
Filing Date
Jan 24, 2019
Document Date
Jan 24, 2019
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
Wave Life Sciences
Issuer
Wave Life Sciences Ltd.